SCHEMBL6404632

SCHEMBL6404632

Cc1nnc(SCC(=O)c2c[nH]c3ccccc23)[nH]1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.66
▸ RECQL P46063 1/20 0.66
▸ KMT2A Q03164 5/20 0.65
▸ MEN1 O00255 3/20 0.65
▸ HTT P42858 2/20 0.65
▸ MAPT P10636 7/20 0.63
▸ ALDH1A1 P00352 4/20 0.63
▸ NPC1 O15118 2/20 0.58
▸ RAB9A P51151 2/20 0.58
▸ MAPK1 P28482 1/20 0.58
▸ SMN1; SMN2 Q16637 3/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.56
▸ LMNA P02545 3/20 0.56
▸ PTGES O14684 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ GAA P10253 1/20 0.56
▸ PKM P14618 2/20 0.53
▸ PSMD14 O00487 1/20 0.53
▸ HBB P68871 1/20 0.53
▸ POLB P06746 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6402456 0.81 KMT2A (0.59) HSD17B10RECQLKMT2AMEN1HTT
SCHEMBL6408206 0.76 ALDH1A1 (0.59) HSD17B10KMT2AHTTMAPTALDH1A1
SCHEMBL30919323 0.75 KMT2A (0.72) HSD17B10RECQLKMT2AMEN1HTT
SCHEMBL15709357 0.75 KMT2A (0.72) HSD17B10RECQLKMT2AMEN1HTT
SCHEMBL15731791 0.72 HSD17B10 (0.65) HSD17B10RECQLKMT2AMEN1HTT
SCHEMBL1903034 0.71 ADAM17 (0.66) KMT2AMEN1HTTMAPTALDH1A1
SCHEMBL17885043 0.71 KMT2A (0.58) HSD17B10RECQLKMT2AMEN1HTT
SCHEMBL9633079 0.70 ADAM17 (0.73) KMT2AMEN1MAPTALDH1A1NPC1
SCHEMBL17214882 0.69 KMT2A (0.48) KMT2AMEN1HTTMAPTALDH1A1
SCHEMBL4056357 0.69 ADAM17 (0.68) KMT2AMEN1HTTMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT HSD17B10 1270/4885RECQL 454/4885KMT2A 2263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback